| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
|---|
| What is an ATC-Code? | ATC-Overview |
|
| | | IP | | | Suprane | 6 x 240 ml | | | k.A. | | Flüssigkeit zur Herstellung eines Dampfs zur Inhalation: Desfluranum 100 % | Baxter AG | B | FB | | G |  |
|
| | | IP | | | Fentanyl-Piramal | 50 x 2 ml | | | k.A. | | Infusion solution: Fentanylum | Piramal Critical Care
Limited, London,
Zweigniederlassung
Rüschlikon | A+ | FB | | G | |
| | | IP | | | Fentanyl-Piramal | 50 x 10 ml | | | k.A. | | Infusion solution: Fentanylum | Piramal Critical Care
Limited, London,
Zweigniederlassung
Rüschlikon | A+ | FB | | G | |
| | | IP | | | Fentanyl Sintetica 0.02
mg/1 ml | 10 1 ampoule(s) à 1 ml | | | k.A. | | Injection solution: Fentanylum 20 µg/ml | Sintetica SA | A+ | FB | | G | |
| | | IP | | | Fentanyl Sintetica 0.05
mg/1 ml | 10 1 ampoule(s) à 2 ml | | | k.A. | | Injection solution: Fentanylum 50 µg/ml | Sintetica SA | A+ | FB | | G | |
| | | IP | | | Fentanyl Sintetica 0.05
mg/1 ml | 10 1 ampoule(s) à 10 ml | | | k.A. | | Injection solution: Fentanylum 50 µg/ml | Sintetica SA | A+ | FB | | G | |
| | | IP | | | Fentanyl-Mepha | 10 | | | k.A. | | Injection solution: Fentanylum 50 µg/ml | Mepha Pharma AG | A+ | FB | | G | |
| | | IP | | | Fentanyl-Mepha | 10 | | | k.A. | | Injection solution: Fentanylum 50 µg/ml | Mepha Pharma AG | A+ | FB | | G | |
| | | IP | | | Fentanyl-Piramal | 10 x 10 ml | | | k.A. | | Infusion solution: Fentanylum | Piramal Critical Care
Limited, London,
Zweigniederlassung
Rüschlikon | A+ | FB | | G | |
| | | | | | Fentanyl-B. Braun i.v. | 10 x 2 ml | | | k.A. | | Injection solution: 2 Active Agents | B. Braun Medical AG | A | FB | | G | |
| | | | | | Fentanyl-B. Braun i.v. | 10 x 5 ml | | | k.A. | | Injection solution: 2 Active Agents | B. Braun Medical AG | A | FB | | G | |
| | | | | | Fentanyl-B. Braun i.v. | 10 x 10 ml | | | k.A. | | Injection solution: 2 Active Agents | B. Braun Medical AG | A | FB | | G | |
|
| | | IP | | A | Rapifen | 5 1 ampoule(s) à 2 ml | | | k.A. | | Infusion solution: Alfentanilum | Piramal Critical Care
Limited, London,
Zweigniederlassung
Rüschlikon | A+ | FB | | G | |
| | | IP | | A | Rapifen | 50 1 ampoule(s) à 10 ml | | | k.A. | | Infusion solution: Alfentanilum | Piramal Critical Care
Limited, London,
Zweigniederlassung
Rüschlikon | A+ | FB | | G | |
|
| | | IP | | | Etomidat-Lipuro | 10 x 10 ml | | | k.A. | | Emulsion: Etomidatum 2 mg | B. Braun Medical SA | B | FB | | G | |
|
| | | IP | | | Distickstoffoxid
medizinal Carbagas | 4 l | | | k.A. | | Inhalation gas: Dinitrogenii Oxidum 100 % | Carbagas AG | B | FB | | G | |
| | | IP | | | Distickstoffoxid
medizinal Carbagas | 10 l | | | k.A. | | Inhalation gas: Dinitrogenii Oxidum 100 % | Carbagas AG | B | FB | | G | |
| | | IP | | | Distickstoffoxid
medizinal Carbagas | 30 l | | | k.A. | | Inhalation gas: Dinitrogenii Oxidum 100 % | Carbagas AG | B | FB | | G | |
| | | IP | | | Distickstoffoxid
medizinal Carbagas | 50 l | | | k.A. | | Inhalation gas: Dinitrogenii Oxidum 100 % | Carbagas AG | B | FB | | G | |
| | | IP | | | Stickoxydul medizinal
MESSER | 3.3 l | | | k.A. | | Gas: Dinitrogenii Oxidum 100 % | Messer Schweiz AG | B | FB | | G | |
| | | IP | | | Stickoxydul medizinal
MESSER | 4 l | | | k.A. | | Gas: Dinitrogenii Oxidum 100 % | Messer Schweiz AG | B | FB | | G | |
| | | IP | | | Stickoxydul medizinal
MESSER | 10 l | | | k.A. | | Gas: Dinitrogenii Oxidum 100 % | Messer Schweiz AG | B | FB | | G | |
| | | IP | | | Stickoxydul medizinal
MESSER | 40 l | | | k.A. | | Gas: Dinitrogenii Oxidum 100 % | Messer Schweiz AG | B | FB | | G | |
| | | IP | | | Stickoxydul medizinal
MESSER | 480 l | | | k.A. | | Gas: Dinitrogenii Oxidum 100 % | Messer Schweiz AG | B | FB | | G | |
| | | IP | | | Stickoxydul medizinal
MESSER | 600 l | | | k.A. | | Gas: Dinitrogenii Oxidum 100 % | Messer Schweiz AG | B | FB | | G | |
| | | IP | | | Distickstoffoxid
medizinal Carbagas | 600 l | | | k.A. | | Inhalation gas: Dinitrogenii Oxidum 100 % | Carbagas AG | B | FB | | G | |
| | | IP | | | Distickstoffoxid
medizinal Linde | 3.5 l | | | k.A. | | Inhalation gas: Dinitrogenii Oxidum 100 % | Linde Gas Schweiz AG | B | FB | | G | |
| | | IP | | | Distickstoffoxid
medizinal Linde | 10 l | | | k.A. | | Inhalation gas: Dinitrogenii Oxidum 100 % | Linde Gas Schweiz AG | B | FB | | G | |
| | | IP | | | Distickstoffoxid
medizinal Linde | 40 l | | | k.A. | | Inhalation gas: Dinitrogenii Oxidum 100 % | Linde Gas Schweiz AG | B | FB | | G | |
| | | IP | | | Distickstoffoxid
medizinal Linde | 600 l | | | k.A. | | Inhalation gas: Dinitrogenii Oxidum 100 % | Linde Gas Schweiz AG | B | FB | | G | |
| | | | | | Distickstoffoxid
medizinal Westfalen 100% | 1 l | | | k.A. | | Gas zur medizinischen Anwendung: Dinitrogenii Oxidum 100 % | Westfalen Gas Schweiz
GmbH | B | FB | | G | |
| | | | | | Distickstoffoxid
medizinal Westfalen 100% | 2 l | | | k.A. | | Gas zur medizinischen Anwendung: Dinitrogenii Oxidum 100 % | Westfalen Gas Schweiz
GmbH | B | FB | | G | |
| | | | | | Distickstoffoxid
medizinal Westfalen 100% | 3 l | | | k.A. | | Gas zur medizinischen Anwendung: Dinitrogenii Oxidum 100 % | Westfalen Gas Schweiz
GmbH | B | FB | | G | |
| | | | | | Distickstoffoxid
medizinal Westfalen 100% | 4 l | | | k.A. | | Gas zur medizinischen Anwendung: Dinitrogenii Oxidum 100 % | Westfalen Gas Schweiz
GmbH | B | FB | | G | |
| | | | | | Distickstoffoxid
medizinal Westfalen 100% | 5 l | | | k.A. | | Gas zur medizinischen Anwendung: Dinitrogenii Oxidum 100 % | Westfalen Gas Schweiz
GmbH | B | FB | | G | |
| | | | | | Distickstoffoxid
medizinal Westfalen 100% | 10 l | | | k.A. | | Gas zur medizinischen Anwendung: Dinitrogenii Oxidum 100 % | Westfalen Gas Schweiz
GmbH | B | FB | | G | |
| | | | | | Distickstoffoxid
medizinal Westfalen 100% | 20 l | | | k.A. | | Gas zur medizinischen Anwendung: Dinitrogenii Oxidum 100 % | Westfalen Gas Schweiz
GmbH | B | FB | | G | |
| | | | | | Distickstoffoxid
medizinal Westfalen 100% | 50 l | | | k.A. | | Gas zur medizinischen Anwendung: Dinitrogenii Oxidum 100 % | Westfalen Gas Schweiz
GmbH | B | FB | | G | |
| | | | | | Distickstoffoxid
medizinal Westfalen 100% | 600 l | | | k.A. | | Gas zur medizinischen Anwendung: Dinitrogenii Oxidum 100 % | Westfalen Gas Schweiz
GmbH | B | FB | | G | |
|
| | | IP | | | Esketamin Sintetica 5
mg/ml | 10 x 5 ml | | | k.A. | | soluzione iniettabile o per infusione: Esketaminum 5 mg/ml | Sintetica SA | ● B | FB | | G | |
| | | IP | | | Esketamin Sintetica 25
mg/ml | 10 x 2 ml | | | k.A. | | soluzione iniettabile o per infusione: Esketaminum 25 mg/ml | Sintetica SA | B | FB | | G | |
| | | IP | | | Esketamin Sintetica 25
mg/ml | 10 x 10 ml | | | k.A. | | soluzione iniettabile o per infusione: Esketaminum 25 mg/ml | Sintetica SA | B | FB | | G | |
|
| | | IP | | | Ampres 30 mg/ml | Durchstechflasche(n) à 20 ml | | | k.A. | | Injection solution: Chloroprocaini Hydrochloridum 30 mg/ml | Sintetica SA | B | FB | | G | |
| | | IP | | | Ampres 20 mg/ml | Durchstechflasche(n) à 20 ml | | | k.A. | | Injection solution: 2 Active Agents | Sintetica SA | B | FB | | G | |
| | | IP | | | Ampres intrathecal 10
mg/ml | 10 x 5 ml | | | k.A. | | Injection solution: Chloroprocaini Hydrochloridum 10 mg/ml | Sintetica SA | B | FB | | G | |
| | | IP | | | Ivracain 5mg/ml | 20 ml | | | k.A. | | Injection solution: Chloroprocaini Hydrochloridum 5 mg/ml | Sintetica SA | B | FB | | G | |
| | | IP | | | Ivracain 5mg/ml | 5 1 ampoule(s) à 20 ml | | | k.A. | | Injection solution: Chloroprocaini Hydrochloridum 5 mg/ml | Sintetica SA | B | FB | | G | |
| | | IP | | | Ampres 10 mg/ml | 10 1 ampoule(s) à 5 ml | | | k.A. | | Injection solution: Chloroprocaini Hydrochloridum 10 mg/ml | Sintetica SA | B | FB | | G | |
| | | IP | | | Ampres 30 mg/ml | 5 1 ampoule(s) à 20 ml | | | k.A. | | Injection solution: Chloroprocaini Hydrochloridum 30 mg/ml | Sintetica SA | B | FB | | G | |
| | | IP | | | Ampres 20 mg/ml | 5 1 ampoule(s) à 20 ml | | | k.A. | | Injection solution: 2 Active Agents | Sintetica SA | B | FB | | G | |
| | | IP | | | Ampres intrathecal 10
mg/ml | 10 x 5 ml | | | k.A. | | Injection solution: Chloroprocaini Hydrochloridum 10 mg/ml | Sintetica SA | B | FB | | G | |
|
| | | IP | | | Bupivacain 5 mg/ml
hyperbar Sintetica | 10 x 4 ml | | | k.A. | | Injection solution: Bupivacaini Hydrochloridum Anhydricum 5 mg/ml | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain 5 mg/ml
hyperbar Sintetica | 10 x 4 ml | | | k.A. | | Injection solution: Bupivacaini Hydrochloridum Anhydricum 5 mg/ml | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 2,5
mg/ml | 10 1 ampoule(s) à 5 ml | | 34.80 | k.A. | | Injection solution: Bupivacaini Hydrochloridum Anhydricum 2.5 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 2,5
mg/ml | 10 x 5 ml | | | k.A. | | Injection solution: Bupivacaini Hydrochloridum Anhydricum 2.5 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 2,5
mg/ml | 5 1 ampoule(s) à 20 ml | | | k.A. | | Injection solution: Bupivacaini Hydrochloridum Anhydricum 2.5 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 5
mg/ml vial | 20 ml | | | k.A. | | Injection solution: Bupivacaini Hydrochloridum Anhydricum 5 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 5
mg/ml ampoule | 10 x 5 ml | | | k.A. | | Injection solution: Bupivacaini Hydrochloridum Anhydricum 5 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 5
mg/ml ampoule | 5 x 20 ml | | | k.A. | | Injection solution: Bupivacaini Hydrochloridum Anhydricum 5 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Carbostesin 0,25 % | 5 1 ampoule(s) à 5 ml | | | k.A. | | Injection solution: Bupivacaini Hydrochloridum Anhydricum 2.5 mg/ml | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | IP | | | Carbostesin 0,25 % | 5 1 ampoule(s) à 20 ml | | | k.A. | | Injection solution: Bupivacaini Hydrochloridum Anhydricum 2.5 mg/ml | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | IP | | | Carbostesin 5 mg/ml
hyperbar | 5 1 ampoule(s) à 4 ml | | 63.40 | k.A. | | Injection solution: Bupivacaini Hydrochloridum Anhydricum 5 mg/ml | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | IP | | | Carbostesin 0,5 % | 5 1 ampoule(s) à 5 ml | | | k.A. | | Injection solution: Bupivacaini Hydrochloridum Anhydricum 5 mg/ml | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | IP | | | Carbostesin 0,5 % | 5 1 ampoule(s) à 20 ml | | | k.A. | | Injection solution: Bupivacaini Hydrochloridum Anhydricum 5 mg/ml | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 40
mg/ml | 10 x 5 ml | | | k.A. | | concentrato per soluzione iniettabile: Bupivacaini Hydrochloridum Anhydricum 40 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 2,5
mg/ml | 20 ml | | | k.A. | | soluzione iniettabile o per infusione: Bupivacaini Hydrochloridum Anhydricum 2.5 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 2,5
mg/ml | 5 x 250 ml | | | k.A. | | soluzione iniettabile o per infusione: Bupivacaini Hydrochloridum Anhydricum 2.5 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 1,25
mg/ml | 50 ml | | | k.A. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum 1.25 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 1,25
mg/ml | 10 x 100 ml | | | k.A. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum 1.25 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 1,25
mg/ml | 5 x 250 ml | | | k.A. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum 1.25 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 5
mg/ml vial | 5 ml | | | k.A. | | Injection solution: Bupivacaini Hydrochloridum Anhydricum 5 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 5
mg/ml ampoule | 10 x 5 ml | | | k.A. | | Injection solution: Bupivacaini Hydrochloridum Anhydricum 5 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 40
mg/ml | 10 1 ampoule(s) à 5 ml | | | k.A. | | concentrato per soluzione iniettabile: Bupivacaini Hydrochloridum Anhydricum 40 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 2,5
mg/ml | 5 ml | | | k.A. | | soluzione iniettabile o per infusione: Bupivacaini Hydrochloridum Anhydricum 2.5 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 2,5
mg/ml | 250 ml | | | k.A. | | soluzione iniettabile o per infusione: Bupivacaini Hydrochloridum Anhydricum 2.5 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 2,5
mg/ml | 500 ml | | | k.A. | | soluzione iniettabile o per infusione: Bupivacaini Hydrochloridum Anhydricum 2.5 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 2,5
mg/ml | 10 x 500 ml | | | k.A. | | soluzione iniettabile o per infusione: Bupivacaini Hydrochloridum Anhydricum 2.5 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica
0.625 mg/ml | 250 ml | | | k.A. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica
0.625 mg/ml | 500 ml | | | k.A. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica
0.625 mg/ml | 5 x 250 ml | | | k.A. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica
0.625 mg/ml | 10 x 500 ml | | | k.A. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 1
mg/ml | 100 ml | | | k.A. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum 1 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 1
mg/ml | 10 x 100 ml | | | k.A. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum 1 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 1,25
mg/ml | 100 ml | | | k.A. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum 1.25 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 1,25
mg/ml | 250 ml | | | k.A. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum 1.25 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 1,25
mg/ml | 1000 ml | | | k.A. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum 1.25 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacain Sintetica 1,25
mg/ml | 5 x 1000 ml | | | k.A. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum 1.25 mg | Sintetica SA | B | FB | | G | |
| | | IP | | | Bupivacaine Sterile Pack 0 | 5 ampoule(s) à 20 ml | | | k.A. | | Injection solution: Bupivacaini Hydrochloridum Anhydricum 5 mg | Abbott AG | B | FB | | G | |
| | | IP | | | Bupivacaine Sterile Pack 0 | 5 ampoule(s) à 20 ml | | | k.A. | | Injection solution: 2 Active Agents | Abbott AG | B | FB | | G | |
| | | IP | | | Bupivacaine Sterile Pack 0 | 5 ampoule(s) à 20 ml | | | k.A. | | Injection solution: Bupivacaini Hydrochloridum Anhydricum 7.5 mg | Abbott AG | B | FB | | G | |
|
| | | IP | | | Carbostesin-Adrenalin
0,25 % | 5 1 Durchstechflasche(n) à 20 ml | | 51.25 | k.A. | | Injection solution: 2 Active Agents | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | IP | | | Carbostesin-Adrenalin 0,5 % | 5 1 Durchstechflasche(n) à 20 ml | | 53.95 | k.A. | | Injection solution: 2 Active Agents | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
|
| | | IP | | | Rudocain | 100 Zylinderampulle(n) | | | k.A. | | Injection solution: 2 Active Agents | Streuli Pharma AG | ● B | FB | | G | |
| | | IP | | | Rudocain forte | 100 Zylinderampulle(n) | | | k.A. | | Injection solution: 2 Active Agents | Streuli Pharma AG | B | FB | | G | |
| | | IP | | | Septanest adrénalinée
1/200.000 | 50 x 1.7 ml | | | k.A. | | Injection solution: 2 Active Agents | Materia Medica
Maibach AG | B | FB | | G | |
| | | IP | | | Septanest adrénalinée
1/100.000 | 50 x 1.7 ml | | | k.A. | | Injection solution: 2 Active Agents | Materia Medica
Maibach AG | B | FB | | G | |
| | | IP | | | Ultracain D-S | 100 1 Zylinderampulle(n) à 1.7 ml | | | k.A. | | Injection solution: 2 Active Agents | Materia Medica
Maibach AG | B | FB | | G | |
| | | IP | | | Ultracain D-S forte | 100 1 Zylinderampulle(n) à 1.7 ml | | | k.A. | | Injection solution: 2 Active Agents | Materia Medica
Maibach AG | B | FB | | G | |
| | | IP | | | Ubistesin mite | 50 x 1.7 ml | | | k.A. | | Injection solution: 2 Active Agents | Medius AG | B | FB | | G | |
| | | IP | | | Ubistesin | 50 1 Zylinderampulle(n) à 1.7 ml | | | k.A. | | Injection solution: 2 Active Agents | Medius AG | B | FB | | G | |
| | | IP | | | Ubistesin forte | 50 1 Zylinderampulle(n) à 1.7 ml | | | k.A. | | Injection solution: 2 Active Agents | Medius AG | B | FB | | G | |
|
| | | IP | | | Aethylchlorid Sintetica | Spray(s) à 100 g | | 6.25 | k.A. | | spray cutaneo: Chloroethanum 100 g | Sintetica SA | B | FB | | G | |
|
| L | | IP | CI | | Qutenza | plaster(s) | 238.37 | 275.65 | 10 % | | kutanes Pflaster: Capsaicinum 179 mg | Grünenthal Pharma AG | A / SL | FB | | G | |
| L | | IP | CI | | Qutenza | 2 plaster(s) | 419.53 | 472.70 | 10 % | | kutanes Pflaster: Capsaicinum 179 mg | Grünenthal Pharma AG | A / SL | FB | | G | |
